Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
They published their findings recently in the Journal of Virology.
Researchers from UGA and Sanofi Pasteur, which has a research and development collaboration agreement with UGA, will present their data tomorrow, March 30, at the World Vaccine Congress US 2016 in Washington, D.C.
“One of the problems with current influenza vaccines is that we have to make predictions about which virus strains will be most prevalent every year and build our vaccines around those predictions,” said Ted Ross, director of UGA’s Center for Vaccines and Immunology and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine. “What we have developed is a vaccine that protects against multiple different strains of H1N1 virus at once, so we might be able to one day replace the current standard of care with this more broadly cross-protective vaccine.”
The H1N1 influenza virus caused a worldwide pandemic in 2009. When it was first detected, it was called swine flu because the virus was similar to those found in pigs, but the virus now circulates as a seasonal form of influenza.
Using a technique called Computationally Optimized Broadly Reactive Antigen, or COBRA, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley, along with Ross, created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.
The COBRA vaccines were designed to recognize H1N1 viruses isolated within the last 100 years, but many of the experimental vaccines produced immunity against influenza strains not included in the design. This means that scientists may be able to produce a vaccine that not only protects against recognized seasonal and pandemic influenza strains, but also strains that have yet to be discovered.
Because this vaccine is generated from the genetic sequences of multiple flu viruses, it may protect against many strains over several years, Ross said. That would also allow for year-round manufacturing of the vaccine, since scientists would not have to halt production every year to identify the most prevalent strains.
This research is part of a broader effort to create a universal influenza vaccine, which would protect against all strains of the virus.
“We still have some work to do before we get a truly universal flu vaccine,” Ross said. “But the COBRA vaccine we’ve developed for H1N1 virus subtypes is a major step in the right direction.”
The Latest on: Flu vaccine
via Google News
The Latest on: Flu vaccine
- Flu vaccine doing a relatively good job this season on February 19, 2019 at 1:52 pm
The flu vaccine is doing a relatively good job this season, protecting about half the people who got it, U.S. health officials said Thursday. Enter your user name and password in the fields above ... […]
- Equine Influenza at World Equestrian Center: More Cases Confirmed on February 19, 2019 at 1:32 pm
World Equestrian Center officials said Feb. 15 that six more horses had tested positive for equine influenza, bringing the total number of confirmed cases to nine. Officials from the World ... […]
- ‘Killer cells’ may pave way for life-long, universal flu vaccine on February 19, 2019 at 11:20 am
MELBOURNE, Feb 19: Killer immune cells that can fight all strains of influenza virus may pave the way for a universal, one-shot flu vaccine, according to a study. These microscopic killers are white b... […]
- ‘Killer cells’ could lead to one-time flu vaccine on February 19, 2019 at 10:50 am
“Killer immune cells” can actually fight all strains of the influenza virus, report researchers. The finding could potentially lead to a universal, one-shot flu vaccine. In the battle against the flu, ... […]
- Top stories in infectious disease: Flu vaccine 47% effective in US, rectal gonorrhea may be predictor of HIV on February 19, 2019 at 10:45 am
Among the top infectious disease stories last week were a report that concluded the influenza vaccine has been 47% effective overall in the US this season but has not been effective protection for old... […]
- Influenza and common cold are completely different diseases, study shows on February 18, 2019 at 10:35 pm
International study shows a lack of public knowledge on the subject There is a lack of information about the difference between influenza, "real" flu, and the common cold. Most people struggle to dist... […]
- Universal one-shot flu vaccine could soon eradicate the disease forever on February 18, 2019 at 3:22 pm
Tired of seasonal flu shots that don't always work? Researchers in Australia might have just discovered the flu shot to end all flu shots-- and possibly, end influenza too, reports MedicalXpress.com. ... […]
- Jamaica on Influenza Alert on February 18, 2019 at 12:52 pm
KINGSTON, Jamaica, Monday February 18, 2019 – The Ministry of Health has placed Jamaica on influenza alert in light of the significant increase in the number of cases of fever and respiratory illnesse... […]
- There’s good news about the flu vaccine this year, especially for kids on February 18, 2019 at 11:38 am
Last year, 80 percent of pediatric deaths occurred in children who were unvaccinated, according to the CDC. Justin Sullivan/Getty Images The first indication of how well the flu vaccine is working thi... […]
- 'Killer' cells raise hope of universal flu vaccine on February 18, 2019 at 11:08 am
Scientists said Monday they had discovered immune cells that can fight all known flu viruses in what was hailed as an "extraordinary breakthrough" that could lead to a universal, one-shot vaccine agai... […]
via Bing News